Targeting IL-6 by engineered Lactococcus lactis via surface-displayed affibody
Abstract Background Dysregulated production of interleukin (IL)-6 is implicated in the pathology of inflammatory bowel disease (IBD). Neutralization of IL-6 in the gut by safe probiotic bacteria may help alleviate intestinal inflammation. Here, we developed Lactococcus lactis with potent and selecti...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2022-07-01
|
| Серии: | Microbial Cell Factories |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s12934-022-01873-7 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|